Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1

Interventions

Cisplatin 223 Radiotherapy 158 Cetuximab 123 pembrolizumab 103 Fluorouracil 84 Docetaxel 82 Paclitaxel 72 Carboplatin 69 Radiotherapy, Intensity-Modulated 62 Nivolumab 34 Radiation 28 Drug Therapy 26 Gemcitabine 23 Erlotinib Hydrochloride 20 Gefitinib 19 Standard of Care 18 durvalumab 17 Surveys and Questionnaires 17 Surgical Procedures, Operative 17 Pemetrexed 17 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 atezolizumab 15 Capecitabine 15 Everolimus 14 Bevacizumab 14 Amifostine 14 Radiosurgery 13 Low-Level Light Therapy 13 Immunohistochemistry 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03989830 2020-10-23

SLICER

Peking University

Phase 2 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡